Four Hours of Sleep and Three Business Plans

First establish whether the episode meets criteria for hypomania at all. A hypomanic episode requires a distinct period of abnormally and persistently elevated, expansive, or irritable mood and increased goal-directed activity or energy lasting at least four days and present most of the day, nearly every day, plus at least three associated symptoms (four if mood is only irritable), a change observable by others, and no marked impairment. Here: five days, decreased need for sleep, increased goal-directed activity (three business plans), excessive involvement in risky spending, pressured speech, and friends observed the change. That satisfies the threshold, and the absence of marked impairment or psychosis argues against mania.

Differential:

• Substance/medication-induced bipolar and related disorder. Sertraline began five weeks before; the episode began in week three - a plausible temporal relationship. Cannabis must also be considered, though the symptom course does not fit intoxication well. This is the leading hypothesis.
• Bipolar II disorder. Requires at least one hypomanic episode and at least one major depressive episode, with the caveat that episodes clearly attributable to an antidepressant do not count toward the bipolar II diagnosis - so whether this qualifies depends on the episode persisting after the medication was stopped. It did not, apparently, which favors the medication-induced designation.
• Bipolar I disorder if impairment or psychosis were marked; not supported here.
• Medical contributors: thyroid disease, anemia, stimulant use - all need exclusion.

A single interview cannot settle this; document the reasoning and the uncertainty.

• Safety first. She has passive suicidal ideation without intent or plan, but she is now off medication, depressed, and post-hypomania - a higher-risk window. Use a structured risk assessment, develop a written safety plan with means restriction and crisis numbers, and document it.
• Contact the prescriber the same day, with a signed release. Report the activation, the timing relative to sertraline, her self-discontinuation, and the family history. Primary care needs this information; withholding it and letting her be restarted on an antidepressant alone would be a foreseeable harm.
• Do not advise medication changes. The counselor does not manage prescriptions; she provides observations and urges psychiatric consultation.
• Refer for psychiatric evaluation, and consider a mood-stabilizer consultation as a medical decision for the prescriber, not the counselor.
• Educate the client about antidepressant-induced activation, why the history matters for future prescribing, and why she should report it rather than stop abruptly on her own.
• Address cannabis use non-judgmentally and assess its role, since it confounds both diagnosis and outcome.
• Begin prospective mood and sleep monitoring with a daily chart that captures sleep need, energy, spending, and irritability - retrospective recall of a five-day episode is unreliable and the chart informs the differential over the next several weeks.
• Obtain informed consent for coordination of care and document every contact.

Problem list: (1) depressive episode, moderate, with passive suicidal ideation; (2) recent hypomania-like episode of five days temporally associated with SSRI initiation; (3) cannabis use; (4) disruption in occupational and financial functioning following the breakup.

Diagnosis: document the medication-induced hypothesis as primary, with bipolar II explicitly listed as under evaluation - for example, substance/medication-induced bipolar and related disorder versus bipolar II disorder, with a note stating what evidence would change the diagnosis (recurrence of hypomania off the medication, a spontaneous episode, or a family-history-driven pattern). Record the reasoning, not just the code, because the diagnostic question is genuinely open and the record will be read by future prescribers.

Goals and objectives (measurable, time-anchored): reduce depressive symptoms and PHQ-9 by at least five points within eight weeks; zero days of suicidal ideation or a documented safety plan followed if they occur; sleep stabilized and charted daily; no unmonitored spending over a set threshold; psychiatric follow-up attended within two weeks.

Interventions: weekly psychotherapy with a mood-focused approach (interpersonal and social rhythm therapy or CBT for depression with relapse prevention); psychoeducation about bipolar spectrum illness and medication-induced activation; sleep and social rhythm regularity; substance use counseling; family involvement with the client's written consent; coordination with the prescriber.

Review: reassess diagnosis and functioning every four to six weeks, adjust the plan, and document the basis for any change. Include the safety plan, the release status, and the client's stated goals in her own words.